Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bumm

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cellular & Molecular Immunology|July 26, 2020
Variant signaling topology at the cancer cell-T-cell interface induced by a two-component T-cell engagerDina Kouhestani, Maria Geis, Saed Alsouri, et al.
Cancer Research|December 6, 2006
Characterization of murine JAK2V617F-positive myeloproliferative diseaseThomas G P Bumm, Collin Elsea, Amie S Corbin, et al.
Blood|June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAnupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
Nature Communications|November 28, 2019
On-target restoration of a split T cell-engaging antibody for precision immunotherapyAgnes Banaszek, Thomas G P Bumm, Boris Nowotny, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cellular & Molecular Immunology|July 26, 2020
Variant signaling topology at the cancer cell-T-cell interface induced by a two-component T-cell engagerDina Kouhestani, Maria Geis, Saed Alsouri, et al.
Cancer Research|December 6, 2006
Characterization of murine JAK2V617F-positive myeloproliferative diseaseThomas G P Bumm, Collin Elsea, Amie S Corbin, et al.
Blood|June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAnupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
Nature Communications|November 28, 2019
On-target restoration of a split T cell-engaging antibody for precision immunotherapyAgnes Banaszek, Thomas G P Bumm, Boris Nowotny, et al.
Pageof 3